Dataset Information


Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study.

ABSTRACT: BACKGROUND:Liposomal amphotericin B (L-AMB) has been used for mucosal leishmaniasis (ML), but comparative studies on L-AMB and other drugs used for the treatment of ML have not been conducted. The present study aimed to evaluate the outcome of patients with ML who were treated with L-AMB. METHODS:This is a 15-year retrospective study of Brazilian patients with a confirmed diagnosis of ML. The therapeutic options for the treatment of ML consisted of L-AMB, amphotericin B lipid complex (ABLC), deoxycholate amphotericin B (d-AMB), itraconazole, antimonial pentavalent, or pentamidine. Healing, cure rate and adverse effects (AEs) associated with the drugs used to treat this condition were analyzed. RESULTS:In 71 patients, a total of 105 treatments were evaluated. The outcome of the treatment with each drug was compared, and results showed that L-AMB was superior to other therapeutic regimens (P = 0.001; odds ratio [OR] = 4.84; 95% confidence interval [CI] = 1.78-13.17). d-AMB had worse AEs than other treatment regimens (P = 0.001, OR = 0.09; 95% CI = 0.09-0.43). Approximately 66% of the patients presented with AEs during ML treatment. Although L-AMB was less nephrotoxic than d-AMB, it was associated with acute kidney injury compared with other drugs (P <0.05). CONCLUSION:L-AMB was more effective than other therapies for the treatment of ML. However, a high incidence of toxicity was associated with its use. Therapeutic choices should be reassessed, and the development of new drugs is necessary for the treatment of ML.


PROVIDER: S-EPMC6594680 | BioStudies | 2019-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-07-28 | GSE12055 | GEO
1000-01-01 | S-EPMC3133483 | BioStudies
2020-01-01 | S-EPMC7508607 | BioStudies
2001-01-01 | S-EPMC90317 | BioStudies
1000-01-01 | S-EPMC5784002 | BioStudies
2019-09-08 | GSE130375 | GEO
2010-05-26 | E-GEOD-10505 | ArrayExpress
2013-01-01 | S-EPMC3642227 | BioStudies
2010-01-01 | S-EPMC3418324 | BioStudies
2020-01-01 | S-EPMC7179636 | BioStudies